Universal Basic Income has been debated for decades. The rise of Quantum AI can make it possible at scale, in sustainable ...

CEO of East Hartford firm that makes virtual reality based systems argues in favor of Connecticut legislation aimed at ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

In this video interview, Michel van Harten, MD, CEO, myTomorrows, discusses where the clinical research industry currently stands with AI adoption.

BridgeBio Pharma, Inc. (NASDAQ:BBIO) announced promising results from its Phase 3 trial of Acoramidis, showing its ability to ...

BMO Capital Markets reaffirmed its “Market Perform” rating and $64.00 price target for Novo Nordisk A/S (NYSE:NVO) following the announcement of a CEO transition. Analysts view the leadership change ...

Precision medicine -> the practice of treating diseases using insights gained from sequencing the human genome is an ...

Positioned to Unlock M&A Value through U.S. Manufacturing Amidst Geopolitical Complexities and Specialty Portfolio ...

The Global Intravenous Catheters Market is on a steady growth trajectory, driven by rising healthcare demands, an aging population, and continuous innovation in intravenous (IV) therapy technologies.

Betsy Groves, Ph.D., is a Solutions Architect at Cohere, where she serves as a trusted technical advisor helping enterprise ...

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vösendorf, Austria on ...

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...